Jean-Baptiste Méar

999 total citations
21 papers, 233 citations indexed

About

Jean-Baptiste Méar is a scholar working on Hematology, Oncology and Infectious Diseases. According to data from OpenAlex, Jean-Baptiste Méar has authored 21 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Jean-Baptiste Méar's work include Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (5 papers) and Acute Myeloid Leukemia Research (4 papers). Jean-Baptiste Méar is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (5 papers) and Acute Myeloid Leukemia Research (4 papers). Jean-Baptiste Méar collaborates with scholars based in France, United States and Switzerland. Jean-Baptiste Méar's co-authors include Rodrigue Dessein, Éric Kipnis, Emmanuel Faure, Benoît Guéry, Karine Faure, Guillaume Schurtz, Aurélie Couturier-Maillard, Michel Chignard, Viviane Balloy and Sylvain Chantepie and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Leukemia.

In The Last Decade

Jean-Baptiste Méar

21 papers receiving 229 citations

Peers

Countries citing papers authored by Jean-Baptiste Méar

Since Specialization

Citations

This map shows the geographic impact of Jean-Baptiste Méar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Baptiste Méar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Baptiste Méar more than expected).

Fields of papers citing papers by Jean-Baptiste Méar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Baptiste Méar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Baptiste Méar. The network helps show where Jean-Baptiste Méar may publish in the future.

Co-authorship network of co-authors of Jean-Baptiste Méar

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Baptiste Méar. A scholar is included among the top collaborators of Jean-Baptiste Méar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Baptiste Méar. Jean-Baptiste Méar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report 2023 ·Journal of Medical Case Reports ·(unknown), Nicolas Belhomme, (unknown), (unknown), (unknown), Jean-Baptiste Méar, Samuel Ardois, Cédric Pastoret, Florian Reizine, Christophe Camus, Benoît Painvin	6
2	P1408: UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) 2023 ·HemaSphere ·Nicolas Boissel, Patrice Chevallier, Kevin J. Curran, Gary J. Schiller, (unknown), Richard A. Larson, Daniel J. DeAngelo, Jean-Baptiste Méar, Stephan A. Grupp, André Baruchel, Marina Konopleva, (unknown), (unknown), (unknown), (unknown), Eric Laille, Daniel J. Lee, Mark G. Frattini, Nitin Jain	8
3	Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T Cell Product Manufactured By Cellectis Biologics, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) 2023 ·Blood ·Nitin Jain, Patrice Chevallier, Hongtao Liu, Gary J. Schiller, Jean-Baptiste Méar, Daniel J. DeAngelo, Kevin J. Curran, Stephan A. Grupp, André Baruchel, Marie Balsat, (unknown), (unknown), (unknown), Kathryn J. Newhall, Eric Laille, Daniel J. Lee, Mark G. Frattini, Richard A. Larson, Nicolas Boissel	13
4	Contribution of voriconazole N‐oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection 2023 ·Mycoses ·(unknown), Jeff Morçet, Lucie‐Marie Scailteux, François Bénézit, Christophe Camus, Jean-Baptiste Méar, Jean‐Pierre Gangneux, Éric Bellissant, Camille Tron, Marie‐Clémence Verdier, F. Lemaı̂tre	5
5	Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia—a Grand Ouest Against Leukemia (GOAL) study 2022 ·Leukemia ·(unknown), Jérémie Riou, Pierre Péterlin, Tony Marchand, (unknown), Alban Villate, Jean-Baptiste Méar, (unknown), Gaëlle Guillerm, Emmanuel Gyan, Aline Schmidt, Roland B. Walter, Mathilde Hunault, Corentin Orvain	4
6	Suivi au moyen-terme des patients faisant l’objet d’un traitement par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) 2021 ·Bulletin du Cancer ·Tamim Alsuliman, Laurianne Drieu La Rochelle, (unknown), Rémy Duléry, (unknown), Anne‐Claire Mamez, Jean-Baptiste Méar, Pascale Schneider, (unknown), (unknown), Ibrahim Yakoub‐Agha	2
7	Single-Unit Transfusion Is Non Inferior to Double Unit Transfusion in Patients with Hematological Disorders Receiving Allogeneic or Autologous Bone Marrow Transplant or Induction Chemotherapy for Acute Leukemia: The 1versus2 Prospective Multicentric Randomized Clinical Trial 2021 ·Blood ·Sylvain Chantepie, Jean-Baptiste Méar, Anaïs R. Briant, Jean‐Pierre Vilque, Anne‐Claire Gac, Stéphane Chèze, Stéphane Girault, Pascal Turlure, Jean‐Pierre Marolleau, Delphine Lebon, A Charbonnier, Fabrice Jardin, Pascal Lenain, Laure Peyro‐Saint‐Paul, (unknown), (unknown), (unknown), (unknown), Oumédaly Reman, Jean‐Jacques Parienti	2
8	Successful and Safe Treatment of Intestinal Graft-Versus-Host Disease (GvHD) with Pooled-Donor Full Ecosystem Microbiota Biotherapeutic: Results from a 29 Patient-Cohort of a Compassionate Use/Expanded Access Treatment Program 2020 ·Blood ·Florent Malard, Michaël Loschi, Faézeh Legrand, Raynier Devillier, (unknown), Cécile Borel, (unknown), Jérôme Cornillon, Amandine Le Bourgeois, Jean-Baptiste Méar, (unknown), Hélène Labussière, (unknown), Claude‐Eric Bulabois, (unknown), Mohamad Mohty	4
9	[Indications and management of hematologic microtransplantation: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)]. 2020 ·Jérôme Cornillon, Martin Carré, Yves Chalandon, Patrice Chevallier, (unknown), Mhamed Harif, (unknown), Jean-Baptiste Méar, Christophe Picard, Ibrahim Yakoub‐Agha, Micha Srour	1
10	Dépistage des bactéries multirésistantes (BMR) et hautement résistantes émergentes (BHRe) aux antibiotiques en allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) 2019 ·Bulletin du Cancer ·Éolia Brissot, Alban Villate, Tamim Alsuliman, David Beauvais, Agnès Bonnin, Jean-Baptiste Méar, Laëtitia Souchet, Ibrahim Yakoub‐Agha, Ali Bazarbachi	2
11	Prophylaxie antivirale pour le CMV, l’HSV/VZV et le VHB après allogreffe de cellules souches hématopoïétiques chez l’adulte : recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC) 2019 ·Bulletin du Cancer ·Éolia Brissot, Tamim Alsuliman, David Beauvais, Agnès Bonnin, Jean-Baptiste Méar, Laëtitia Souchet, Alban Villate, Ibrahim Yakoub‐Agha, Ali Bazarbachi	9
12	Successful and Safe Treatment of Intestinal Graft-Versus-Host Disease (GvHD) with Pooled-Donor Full Ecosystem Microbiota Biotherapeutics 2019 ·Blood ·Florent Malard, Faézeh Legrand, Jérôme Cornillon, Amandine Le Bourgeois, Jean-Baptiste Méar, (unknown), (unknown), Ronald Carter, (unknown), Patrice Chevallier, Denis Guyotat, Didier Blaise, Mohamad Mohty	2
13	Increased frequencies of circulating and tumor-resident Vδ1⁺T cells in patients with diffuse large B-cell lymphoma 2017 ·Leukemia & lymphoma ·(unknown), Anne‐Claire Gac, (unknown), Véronique Salaün, Oumédaly Reman, (unknown), (unknown), (unknown), Jean‐Pierre Vilque, Christophe Fruchart, Sylvain Chantepie, Hyacinthe Johnson‐Ansah, Margaret Macro, Stéphane Chèze, (unknown), Jean-Baptiste Méar, Xavier Troussard, Gandhi Damaj, Brigitte Le Mauff, Olivier Toutirais	17
14	Blood transfusion in hematologic intensive care unit 2016 ·Transfusion ·Sylvain Chantepie, Jean-Baptiste Méar, Jean‐Jacques Parienti, (unknown), (unknown), Stéphane Chèze, Anne‐Claire Gac, Hyacinthe Johnson‐Ansah, Margaret Macro, (unknown), (unknown), (unknown), Gandhi Damaj, Oumédaly Reman	11
15	Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial 2015 ·Trials ·Sylvain Chantepie, Jean-Baptiste Méar, Lydia Guittet, B. Dervaux, Jean‐Pierre Marolleau, Fabrice Jardin, (unknown), Jean‐Jacques Parienti, Jean‐Pierre Vilque, Oumédaly Reman	9
16	Unusual Extramedullary Plasmacytoma: A Rare but Possible Cause of Lymphadenopathy in Chronic Lymphocytic Leukemia 2015 ·Case Reports in Medicine ·Sylvain Chantepie, (unknown), Jean-Baptiste Méar, Véronique Salaün, Emmanuèle Lechapt, Margaret Macro	1
17	Pseudomonas aeruginosa Type-3 Secretion System Dampens Host Defense by Exploiting the NLRC4-coupled Inflammasome 2014 ·American Journal of Respiratory and Critical Care Medicine ·Emmanuel Faure, Jean-Baptiste Méar, Karine Faure, Sylvain Normand, Aurélie Couturier-Maillard, Teddy Grandjean, Viviane Balloy, Bernhard Ryffel, Rodrigue Dessein, Michel Chignard, Catherine Uyttenhove, Benoît Guéry, Philippe Gosset, Mathias Chamaillard, Éric Kipnis	69
18	Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia 2014 ·Leukemia & lymphoma ·Sylvain Chantepie, (unknown), Jean-Baptiste Méar, Anne‐Claire Gac, Véronique Salaün, (unknown), Stéphane Chèze, Hyacinthe Johnson‐Ansah, Margaret Macro, Jean‐Pierre Vilque, Oumédaly Reman	13
19	A Restrictive Strategy Reduces the Number of Transfused Packed Red Blood Cells in Allograft Recipients 2014 ·Blood ·Jean-Baptiste Méar, Sylvain Chantepie, Anne‐Claire Gac, (unknown), Oumédaly Reman	4
20	Candida albicans and Pseudomonas aeruginosa interactions: More than an opportunistic criminal association? 2013 ·Médecine et Maladies Infectieuses ·Jean-Baptiste Méar, Éric Kipnis, Emmanuel Faure, Rodrigue Dessein, Guillaume Schurtz, Karine Faure, Benoît Guéry	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact